Are all cases of paediatric essential thrombocythaemia really myeloproliferative neoplasms? Analysis of a large cohort

Type 1 versus Type 2 calreticulin mutations in essential thrombocythemia: A collaborative study of 1027 patients

(2014) Ayalew Tefferi et al.   AMERICAN JOURNAL OF HEMATOLOGY

CALR mutations in patients with essential thrombocythemia diagnosed in childhood and adolescence

(2014) F. Giona et al.   BLOOD

Integrated genomic analysis illustrates the central role of JAK-STAT pathway activation in myeloproliferative neoplasm pathogenesis

(2014) R. Rampal et al.   BLOOD

Primary thrombocytosis in children

(2014) N. Kucine et al.   HAEMATOLOGICA

Calreticulin mutations and long-term survival in essential thrombocythemia

(2014) A Tefferi et al.   LEUKEMIA

CALRmutations are rare in childhood essential thrombocythemia

(2014) Stephen E. Langabeer et al.   PEDIATRIC BLOOD & CANCER

Distinct driver mutation profiles of childhood and adolescent essential thrombocythemia

(2014) Stephen E. Langabeer et al.   PEDIATRIC BLOOD & CANCER

Impact of calreticulin mutations on clinical and hematological phenotype and outcome in essential thrombocythemia

(2013) G. Rotunno et al.   BLOOD

JAK2 or CALR mutation status defines subtypes of essential thrombocythemia with substantially different clinical course and outcomes

(2013) E. Rumi et al.   BLOOD

Paediatric essential thrombocythaemia: clinical and molecular features, diagnosis and treatment

(2013) Rongfeng Fu et al.   BRITISH JOURNAL OF HAEMATOLOGY

Idiopathic Myelofibrosis in Children

(2013) Jeremy S. Slone et al.   JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY

Somatic CALR Mutations in Myeloproliferative Neoplasms with Nonmutated JAK2

(2013) J. Nangalia et al.   NEW ENGLAND JOURNAL OF MEDICINE

Somatic Mutations of Calreticulin in Myeloproliferative Neoplasms

(2013) Thorsten Klampfl et al.   NEW ENGLAND JOURNAL OF MEDICINE

MPL W515L mutation in pediatric essential thrombocythemia

(2013) Piero Farruggia et al.   PEDIATRIC BLOOD & CANCER

Thrombocythemia and polycythemia in patients younger than 20 years at diagnosis: clinical and biologic features, treatment, and long-term outcome

(2012) F. Giona et al.   BLOOD

Spontaneous Resolution of Extreme Thrombocytosis in 2 Children

(2012) Shraga Aviner et al.   PEDIATRIC HEMATOLOGY AND ONCOLOGY

Philadelphia-Negative Classical Myeloproliferative Neoplasms: Critical Concepts and Management Recommendations From European LeukemiaNet

(2011) Tiziano Barbui et al.   JOURNAL OF CLINICAL ONCOLOGY

The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes

(2009) J. W. Vardiman et al.   BLOOD

The mutantJAK2V617Fallele burden in children with essential thrombocythemia

(2009) Luciana Teofili et al.   BRITISH JOURNAL OF HAEMATOLOGY

MPL mutations in myeloproliferative disorders: analysis of the PT-1 cohort

(2008) P. A. Beer et al.   BLOOD